Drug
Lanthanum Carbonate
Lanthanum Carbonate: highest development phase Phase 3, developed by Bayer. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Bayer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lanthanum carbonate (BAY77-1931) NCT01514851 | Phase 3 | Hyperphosphatemia |
| Lanthanum Carbonate (BAY77-1931) NCT00767637 | Phase 2 | Hyperphosphatemia |
Latest
No recent events.
Follow Lanthanum Carbonate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.